Profound Medical Corp. Completes Previously Announced $17.4M Bought Deal Offering of Common Shares

Read Article

Toronto’s Xagenic Inc. completes successful beta testing of X1 diagnostic system

Read Article

Immunovaccine’s Preclinical DPX-NEO Program Demonstrates Positive Anti-Cancer Activity

Read Article

Venous infers_Early work sufficient to attract $21M for Ilkos leg ulcers effort

Read Article

Immunovaccine Announces Closing of $8M Bought Deal Private Placement Financing

Read Article

Zymeworks and GSK Enter Second Strategic Collaboration to Develop and Commercialize Bi-Specific Antibodies

Read Article

Zymeworks Names Diana Hausman, M.D. Chief Medical Officer

Read Article

DalCor raises $100M in series B

Read Article

Biotech upstart gambles $150M believing it can succeed after Big Pharmas failed on CETP

Read Article

With $150M in the bank, Dalcor seeks phase III success with dalcetrapib

Read Article

Startup Aims to Revive Failed Drug

Read Article

Xagenic readies X1 molecular diagnostic beta trials

Read Article

Zymeworks Completes Acquisition of Kairos Therapeutics Creating a Leader in Biologics Drug Discovery and Development

Read Article

Zymeworks Announces $61.5M Financing to Support the Clinical Development of its Pipeline of Azymetric™ Antibody Therapeutics

Read Article